Works matching DE "ROSIGLITAZONE"
Results: 692
Improvement of Insulin Sensitivity by a Novel Drug Candidate, BGP-15, in Different Animal Studies.
- Published in:
- Metabolic Syndrome & Related Disorders, 2014, v. 12, n. 2, p. 125, doi. 10.1089/met.2013.0098
- By:
- Publication type:
- Article
Portable Dual‐Modular Immunosensor Constructed from Bimetallic Metal–Organic Framework Heterostructure Grafted with Enzyme‐Mimicking Label for Rosiglitazone Detection.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 30, p. 1, doi. 10.1002/adfm.202203244
- By:
- Publication type:
- Article
Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation.
- Published in:
- Calcified Tissue International, 2012, v. 91, n. 2, p. 139, doi. 10.1007/s00223-012-9623-4
- By:
- Publication type:
- Article
The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial.
- Published in:
- Calcified Tissue International, 2010, v. 86, n. 5, p. 343, doi. 10.1007/s00223-010-9352-5
- By:
- Publication type:
- Article
Thiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 4, p. 385, doi. 10.1007/s00228-015-1999-4
- By:
- Publication type:
- Article
Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 6, p. 1311, doi. 10.1007/s00228-012-1467-3
- By:
- Publication type:
- Article
Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 709, doi. 10.1007/s00228-011-1177-2
- By:
- Publication type:
- Article
A randomised controlled trial on melatonin and rosiglitazone for prevention of adhesion formation in a rat uterine horn model.
- Published in:
- Archives of Gynecology & Obstetrics, 2010, v. 282, n. 1, p. 55, doi. 10.1007/s00404-009-1240-8
- By:
- Publication type:
- Article
Seven days: 29 November-5 December 2013.
- Published in:
- Nature, 2013, v. 504, n. 7478, p. 12, doi. 10.1038/504012a
- Publication type:
- Article
Seven days: 7-13 June 2013.
- Published in:
- Nature, 2013, v. 498, n. 7453, p. 142, doi. 10.1038/498142a
- Publication type:
- Article
Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor.
- Published in:
- Endocrine Research, 2013, v. 38, n. 3, p. 168, doi. 10.3109/07435800.2012.746364
- By:
- Publication type:
- Article
Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 7, p. 1593, doi. 10.1038/npp.2010.32
- By:
- Publication type:
- Article
Challenges and Opportunities for Biomarker Validation.
- Published in:
- Journal of Law, Medicine & Ethics, 2019, v. 47, n. 3, p. 357, doi. 10.1177/1073110519876162
- Publication type:
- Article
miRNA-9-5p 与NF-资B 信号通路在2 型糖尿病肾病发病中的作用机制.
- Published in:
- Progress in Modern Biomedicine, 2019, v. 19, n. 17, p. 3239, doi. 10.13241/j.cnki.pmb.2019.17.008
- By:
- Publication type:
- Article
No causal effects between rosiglitazone and cardiovascular disease or risk factors: a Mendelian randomization study.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 11, p. 5280
- By:
- Publication type:
- Article
Rosiglitazone May Assist With Glycemic Control in the ICU.
- Published in:
- Journal of Intensive Care Medicine, 2010, v. 25, n. 2, p. 117, doi. 10.1177/0885066609355264
- By:
- Publication type:
- Article
Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1‐year randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1740, doi. 10.1111/dom.13293
- By:
- Publication type:
- Article
Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 10, p. 949, doi. 10.1111/dom.12487
- By:
- Publication type:
- Article
Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 4, p. 335, doi. 10.1111/dom.12380
- By:
- Publication type:
- Article
APOE* 3Leiden. CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 6, p. 537, doi. 10.1111/dom.12252
- By:
- Publication type:
- Article
Observational follow-up of the PROactive study: a 6-year update.
- Published in:
- Diabetes, Obesity & Metabolism, 2014, v. 16, n. 1, p. 63, doi. 10.1111/dom.12180
- By:
- Publication type:
- Article
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
- Published in:
- Diabetes, Obesity & Metabolism, 2013, v. 15, n. 11, p. 967, doi. 10.1111/dom.12101
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 7, p. 673, doi. 10.1111/j.1463-1326.2012.01621.x
- By:
- Publication type:
- Article
The design of the liraglutide clinical trial programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, p. 4, doi. 10.1111/j.1463-1326.2012.01573.x
- By:
- Publication type:
- Article
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
- Published in:
- Diabetes, Obesity & Metabolism, 2012, v. 14, n. 2, p. 181, doi. 10.1111/j.1463-1326.2011.01510.x
- By:
- Publication type:
- Article
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na ïve type 2 diabetes mellitus patients
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 11, p. 1036, doi. 10.1111/j.1463-1326.2011.01461.x
- By:
- Publication type:
- Article
Cardiovascular risk and thiazolidinediones-what do meta-analyses really tell us?
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 12, p. 1023, doi. 10.1111/j.1463-1326.2010.01262.x
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 11, p. 1019, doi. 10.1111/j.1463-1326.2010.01310.x
- By:
- Publication type:
- Article
Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 9, p. 825, doi. 10.1111/j.1463-1326.2010.01234.x
- By:
- Publication type:
- Article
Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 9, p. 806, doi. 10.1111/j.1463-1326.2010.01237.x
- By:
- Publication type:
- Article
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 8, p. 716, doi. 10.1111/j.1463-1326.2010.01225.x
- By:
- Publication type:
- Article
Selective effects of PPARγ agonists and antagonists on human pre-adipocyte differentiation.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 3, p. 195, doi. 10.1111/j.1463-1326.2009.01149.x
- By:
- Publication type:
- Article
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 12, p. 1091, doi. 10.1111/j.1463-1326.2009.01087.x
- By:
- Publication type:
- Article
FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF ROSIGLITAZONE MALEATE.
- Published in:
- International Journal of Pharmaceutical, Chemical & Biological Sciences, 2016, v. 6, n. 2, p. 182
- By:
- Publication type:
- Article
FORMULATION AND EVALUATION OF FLOATING MICROSPHERES OF ROSIGLITAZONE.
- Published in:
- International Journal of Pharmaceutical, Chemical & Biological Sciences, 2015, v. 5, n. 4, p. 907
- By:
- Publication type:
- Article
Role of peroxisome proliferator–activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus.
- Published in:
- Human & Experimental Toxicology, 2018, v. 37, n. 11, p. 1187, doi. 10.1177/0960327118757588
- By:
- Publication type:
- Article
Effects of prenatal PPAR-γ agonist rosiglitazone exposure on rat hippocampus development in a timedependent manner: A stereological and histopathological study.
- Published in:
- Human & Experimental Toxicology, 2018, v. 37, n. 8, p. 827, doi. 10.1177/0960327117730883
- By:
- Publication type:
- Article
A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 6, p. 1343, doi. 10.1185/03007990902870084
- By:
- Publication type:
- Article
In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 4, p. 891, doi. 10.1185/03007990902790928
- By:
- Publication type:
- Article
After Avandia.
- Published in:
- Texas Heart Institute Journal, 2012, v. 39, n. 2, p. 174
- By:
- Publication type:
- Article
Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats.
- Published in:
- ISRN Pharmacology, 2012, p. 1, doi. 10.5402/2012/130347
- By:
- Publication type:
- Article
Thiazolidinediones: Understanding their role in diabetes management.
- Published in:
- African Journal of Diabetes Medicine, 2024, v. 32, n. 3, p. 9, doi. 10.54931/AJDM-32.3.4
- By:
- Publication type:
- Article
DOSE RELATED STUDY IN NORMAL MICE AND ANTIDIABETIC EFFECT OF NATURAL EXTRACTS IN STREPTOZOTOCIN INDUCED DIABETIC MICE.
- Published in:
- International Journal of Pharmacology & Biological Sciences, 2011, v. 5, n. 3, p. 7
- By:
- Publication type:
- Article
The PPAR? Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.
- Published in:
- Pulmonary Medicine, 2012, p. 1, doi. 10.1155/2012/545172
- By:
- Publication type:
- Article
Effects of rosiglitazone pretreatment on blood glucose, lipid levels, urea, and microalbuminuria in rats undergoing 70% pancreatectomy.
- Published in:
- Open Access Surgery, 2013, v. 6, p. 1, doi. 10.2147/OAS.S39364
- By:
- Publication type:
- Article
Preparation and characterization of superporous hydrogels as gastroretentive drug delivery system for rosiglitazone maleate.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2010, v. 18, n. 3, p. 200
- By:
- Publication type:
- Article
Behind the rosiglitazone controversy.
- Published in:
- Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 723, doi. 10.1586/ecp.10.126
- By:
- Publication type:
- Article
Cardiovascular Safety of New Drugs for Diabetes: Getting the Balance Right?
- Published in:
- Pharmaceutical Medicine, 2014, v. 28, n. 3, p. 109, doi. 10.1007/s40290-014-0053-7
- By:
- Publication type:
- Article
The Pharmaceutical Medicine Year that Was.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010.
- Published in:
- BMC Research Notes, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-0500-6-82
- By:
- Publication type:
- Article